US OptionsDetailed Quotes
PFE250110P26500
- 0.01
- 0.000.00%
15min DelayClose Jan 10 16:00 ET
0.00High0.00Low
0.00Open0.01Pre Close0 Volume2.58K Open Interest26.50Strike Price0.00Turnover652.52%IV-0.19%PremiumJan 10, 2025Expiry Date0.06Intrinsic Value100Multiplier-13DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.1083Delta0.9704Gamma2644.00Leverage Ratio-39.8565Theta0.0000Rho-286.34Eff Leverage0.0001Vega
Pfizer Stock Discussion
1. $Pfizer (PFE.US)$'s shares rose 1.6% on Thursday, with the most traded calls are contracts of $25 strike price that expire on Jan 24 and the total volume reaching 77,418 with the open interest of 10,228.
Pfizer was the target of unusually large options trading on Thursday. Stock investors purchased 251,131 call options on the company. This represents an increase of 54% co...
Tomorrow is the XD.
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...
Alright, im dreaming
Pfizer has completed a secondary offering of 700 million Haleon ordinary shares at 357 pence (approximately $4.36) per share on January 17, 2025. The sale was executed through a block trade agreement with multiple financial institutions including J.P. Morgan Securities, Morgan Stanley, HSBC, and others.
Following the transaction, Pfizer now holds 661,709,764 Haleon ordinary shares, representing approximately 7.3% of Haleon's outstanding shares. This includes 197,228,952 restric...
No comment yet